Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets (Unaudited)

v3.19.1
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents [note 5] $ 7,320 $ 9,515
Short-term investments [note 5] 2,345 5,089
Prepaid expenses and other assets 866 933
Total current assets 10,531 15,537
Restricted cash [note 5] 50 50
Property and equipment, net 80 35
Operating lease right-of-use assets [note 7] 455  
Other assets 97 118
License agreement [note 3 and 4] 2,254 2,310
Goodwill [note 4] 1,034 1,034
Total assets 14,501 19,084
Current liabilities:    
Accounts payable 694 144
Accrued liabilities other 545 748
Accrued clinical liabilities 2,086 1,199
Accrued compensation 488 1,168
Current portion of obligations [note 7] 16 11
Current portion of lease liability [note 7] 170  
Total current liabilities 3,999 3,270
Long-term obligations [note 7] 24 12
Long-term lease liability [note 7] 289  
Total liabilities 4,312 3,282
Commitments and contingencies [note 7]
Stockholders' equity:    
Series A convertible preferred stock, $0.001 par value, 5,000,000 shares authorized, 579 issued and outstanding at March 31, 2019 and 579 issued and outstanding at December 31, 2018.
Common stock, $0.001 par value, 150,000,000 shares authorized, 6,721,200 issued and outstanding at March 31, 2019 and 6,721,117 issued and outstanding at December 31, 2018, respectively. 18 18
Additional paid-in capital 41,455 41,161
Accumulated deficit (31,288) (25,381)
Accumulated other comprehensive income 4 4
Total stockholders' equity 10,189 15,802
Total liabilities and stockholders' equity $ 14,501 $ 19,084